Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial? (Q47384272)
Jump to navigation
Jump to search
scientific article published on 27 September 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial? |
scientific article published on 27 September 2016 |
Statements
Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial? (English)
Subodh Verma
Ankit Garg
Andrew T Yan
Anup K Gupta
Mohammed Al-Omran
Andre Sabongui
C David Mazer
27 September 2016